Africa Western and Central vs South Korea: Immunization, Hib3
Immunization, Hib3 over time
- Africa Western and Central
- South Korea
How they compare
South Korea currently reports 97.0% against 74.3% in Africa Western and Central, a difference of 22.7%.
That makes South Korea's figure about 1.3 times Africa Western and Central's.
Across all 11 years both countries report, South Korea has been ahead every year.
Africa Western and Central ranks 31st and South Korea ranks 29th of 43 groups.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa Western and Central | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.0% | 97.5% | 31.5% | South Korea |
| 2020s | 71.4% | 96.6% | 25.2% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Africa Western and Central or South Korea?
- South Korea, at 97.0% against 74.3% in Africa Western and Central as of 2024.
- What is the difference in immunization, hib3 between Africa Western and Central and South Korea?
- 22.7%, with South Korea ahead.
- How many years of comparable data are there for Africa Western and Central and South Korea?
- 11 years are reported by both, from 2014 to 2024.
- How do Africa Western and Central and South Korea rank globally for immunization, hib3?
- Africa Western and Central ranks 31st and South Korea ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.